Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NGL FINE CHM VENUS REMEDIES NGL FINE CHM/
VENUS REMEDIES
 
P/E (TTM) x 33.7 15.0 224.1% View Chart
P/BV x 5.8 0.9 612.2% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 NGL FINE CHM   VENUS REMEDIES
EQUITY SHARE DATA
    NGL FINE CHM
Mar-23
VENUS REMEDIES
Mar-23
NGL FINE CHM/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs2,569379 678.0%   
Low Rs1,161145 800.9%   
Sales per share (Unadj.) Rs450.0415.5 108.3%  
Earnings per share (Unadj.) Rs33.219.9 166.9%  
Cash flow per share (Unadj.) Rs51.444.0 116.8%  
Dividends per share (Unadj.) Rs1.750-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs360.1344.3 104.6%  
Shares outstanding (eoy) m6.1813.37 46.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.10.6 657.4%   
Avg P/E ratio x56.213.2 426.5%  
P/CF ratio (eoy) x36.35.9 609.4%  
Price / Book Value ratio x5.20.8 680.7%  
Dividend payout %5.30-   
Avg Mkt Cap Rs m11,5233,501 329.1%   
No. of employees `000NANA-   
Total wages/salary Rs m369570 64.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,7815,555 50.1%  
Other income Rs m55103 53.6%   
Total revenues Rs m2,8365,658 50.1%   
Gross profit Rs m350602 58.1%  
Depreciation Rs m113323 35.0%   
Interest Rs m183 623.8%   
Profit before tax Rs m274379 72.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m69114 60.4%   
Profit after tax Rs m205266 77.2%  
Gross profit margin %12.610.8 116.0%  
Effective tax rate %25.130.0 83.7%   
Net profit margin %7.44.8 154.1%  
BALANCE SHEET DATA
Current assets Rs m1,6273,230 50.4%   
Current liabilities Rs m583826 70.6%   
Net working cap to sales %37.543.3 86.7%  
Current ratio x2.83.9 71.3%  
Inventory Days Days6537 176.5%  
Debtors Days Days865504 171.7%  
Net fixed assets Rs m1,2442,781 44.7%   
Share capital Rs m31134 23.1%   
"Free" reserves Rs m2,1954,470 49.1%   
Net worth Rs m2,2254,603 48.3%   
Long term debt Rs m21387 5.4%   
Total assets Rs m2,8716,011 47.8%  
Interest coverage x15.9130.0 12.2%   
Debt to equity ratio x00.1 11.1%  
Sales to assets ratio x1.00.9 104.8%   
Return on assets %7.84.5 174.1%  
Return on equity %9.25.8 159.6%  
Return on capital %13.07.7 169.7%  
Exports to sales %74.30-   
Imports to sales %9.90-   
Exports (fob) Rs m2,066NA-   
Imports (cif) Rs m276NA-   
Fx inflow Rs m2,0950-   
Fx outflow Rs m3040-   
Net fx Rs m1,7900-   
CASH FLOW
From Operations Rs m353366 96.3%  
From Investments Rs m-270-508 53.2%  
From Financial Activity Rs m-11-6 190.3%  
Net Cashflow Rs m72-220 -32.6%  

Share Holding

Indian Promoters % 73.1 41.8 175.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 1.6 2.5%  
FIIs % 0.0 1.6 2.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.9 58.2 46.3%  
Shareholders   16,410 19,560 83.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NGL FINE CHM With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on NGL FINE CHM vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NGL FINE CHM vs VENUS REMEDIES Share Price Performance

Period NGL FINE CHM VENUS REMEDIES S&P BSE HEALTHCARE
1-Day -0.58% 7.05% 1.18%
1-Month 2.94% -4.10% -0.75%
1-Year 77.47% 103.11% 61.82%
3-Year CAGR 9.82% 4.62% 18.16%
5-Year CAGR 35.36% 58.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the NGL FINE CHM share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of NGL FINE CHM hold a 73.1% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NGL FINE CHM and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, NGL FINE CHM paid a dividend of Rs 1.8 per share. This amounted to a Dividend Payout ratio of 5.3%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of NGL FINE CHM, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.